http://www.drugdiscoverynews.com/index.php?newsarticle=5055
type 2 diabetes biomarkers... cheerier stuff this time... A major public-private biomedical research partnership led by the National Institutes of Health (NIH) has launched a landmark clinical study of patients at risk for rapid beta cell function deterioration that may inform future studies of diabetes progression.
type 2 diabetes biomarkers... cheerier stuff this time... A major public-private biomedical research partnership led by the National Institutes of Health (NIH) has launched a landmark clinical study of patients at risk for rapid beta cell function deterioration that may inform future studies of diabetes progression.
